Your browser doesn't support javascript.
loading
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.
Saketkoo, Lesley Ann; Frech, Tracy; Varjú, Cecília; Domsic, Robyn; Farrell, Jessica; Gordon, Jessica K; Mihai, Carina; Sandorfi, Nora; Shapiro, Lee; Poole, Janet; Volkmann, Elizabeth R; Lammi, Monika; McAnally, Kendra; Alexanderson, Helene; Pettersson, Henrik; Hant, Faye; Kuwana, Masataka; Shah, Ami A; Smith, Vanessa; Hsu, Vivien; Kowal-Bielecka, Otylia; Assassi, Shervin; Cutolo, Maurizio; Kayser, Cristiane; Shanmugam, Victoria K; Vonk, Madelon C; Fligelstone, Kim; Baldwin, Nancy; Connolly, Kerri; Ronnow, Anneliese; Toth, Beata; Suave, Maureen; Farrington, Sue; Bernstein, Elana J; Crofford, Leslie J; Czirják, László; Jensen, Kelly; Hinchclif, Monique; Hudson, Marie; Lammi, Matthew R; Mansour, Jennifer; Morgan, Nadia D; Mendoza, Fabian; Nikpour, Mandana; Pauling, John; Riemekasten, Gabriela; Russell, Anne-Marie; Scholand, Mary Beth; Seigart, Elise; Rodriguez-Reyna, Tatiana Sofia.
Afiliación
  • Saketkoo LA; New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, USA; Tulane University School of Medicine, New Orleans, USA; Louisiana State University School of Medicine, Section of Pulmonary Medicine, New Orleans, USA; University Medical Center - Comprehensive Pulmonary Hype
  • Frech T; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Varjú C; Department of Rheumatology and Immunology, Medical School, University of Pécs, Pécs, Hungary.
  • Domsic R; University of Pittsburgh, Pittsburgh, PA, USA.
  • Farrell J; Albany College of Pharmacy and Health Sciences, Albany, NY, USA; Steffens Scleroderma Foundation, Albany, NY, USA.
  • Gordon JK; Department of Rheumatology at Hospital for Special Surgery, New York, NY, USA.
  • Mihai C; Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Internal Medicine and Rheumatology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Sandorfi N; Perelman School of Medicine, Philadelphia, PA, USA.
  • Shapiro L; Steffens Scleroderma Foundation, Albany, NY, USA; Division of Rheumatology, Albany Medical Center, Albany, NY, USA.
  • Poole J; Occupational Therapy Graduate Program, University of New Mexico, Albuquerque, NM, USA.
  • Volkmann ER; University of California, David Geffen School of Medicine, UCLA Scleroderma Program and UCLA CTD-ILD Program, Division of Rheumatology, Department of Medicine, Los Angeles, CA, USA.
  • Lammi M; Ochsner Medical Center, New Orleans, LA, USA.
  • McAnally K; Norton Thoracic Institute, St. Joseph's Hospital and Medical Centre, Phoenix, AZ, USA.
  • Alexanderson H; Function Allied Health Professionals, Medical Unit Occupational Therapy and Physiotherapy, Karolinska University Hospital, Stockholm, Sweden; Department of Medicin, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Pettersson H; Function Allied Health Professionals, Medical Unit Occupational Therapy and Physiotherapy, Karolinska University Hospital, Stockholm, Sweden; Department of Medicin, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Hant F; Division of Rheumatology, Medical University of South Caroline, SC, USA.
  • Kuwana M; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.
  • Shah AA; Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Smith V; Department of Internal Medicine, Ghent University, and Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
  • Hsu V; Rutgers- RWJ Scleroderma Program, New Brunswick, NJ, USA.
  • Kowal-Bielecka O; Department of Rheumatology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.
  • Assassi S; Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Cutolo M; Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Polyclinic San Martino Hospital, Genova, Italy.
  • Kayser C; Escola Paulista de Medicina, Federal University of São Paulo (UNIFESP) São Paulo, SP, Brazil.
  • Shanmugam VK; Department of Rheumatology, George Washington University, School of Medicine and Health Sciences, Washington, DC, USA.
  • Vonk MC; Department of the rheumatic diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Fligelstone K; Patient Research Partner, Scleroderma & Raynaud Society UK (SRUK), London, UK; Royal Free Hospital, London, UK.
  • Baldwin N; Patient Research Partner, Scleroderma Foundation, Chicago, IL, USA.
  • Connolly K; Scleroderma Foundation, Danvers, MA, USA.
  • Ronnow A; Federation of European Scleroderma Associations, Copenhagen, Denmark; Federation of European Scleroderma Associations, Budapest, Hungary; Federation of European Scleroderma Associations, London, UK.
  • Toth B; Federation of European Scleroderma Associations, Copenhagen, Denmark; Federation of European Scleroderma Associations, Budapest, Hungary; Federation of European Scleroderma Associations, London, UK.
  • Suave M; Scleroderma Canada, Canada.
  • Farrington S; Patient Research Partner, Scleroderma & Raynaud Society UK (SRUK), London, UK; Federation of European Scleroderma Associations, Copenhagen, Denmark; Federation of European Scleroderma Associations, Budapest, Hungary; Federation of European Scleroderma Associations, London, UK.
  • Bernstein EJ; Columbia University/New York-Presbyterian Scleroderma Program, Division of Rheumatology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA.
  • Crofford LJ; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Czirják L; Department of Rheumatology and Immunology, Medical School, University of Pécs, Pécs, Hungary.
  • Jensen K; Tulane University School of Medicine, New Orleans, USA; Oregon Health and Science University, Portland, OR, USA.
  • Hinchclif M; Yale School of Medicine, Department of Internal Medicine, Section of Rheumatology, Allergy & Immunology, USA.
  • Hudson M; Division of heumatology and Department of Medicine, Jewish General Hospital and McGill University, Montreal, QC, Canada.
  • Lammi MR; New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, USA; Louisiana State University School of Medicine, Section of Pulmonary Medicine, New Orleans, USA; University Medical Center - Comprehensive Pulmonary Hypertension Center and Interstitial Lung Disease Clinic Pro
  • Mansour J; Tulane University School of Medicine, New Orleans, USA.
  • Morgan ND; Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Mendoza F; Rheumatology Division, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
  • Nikpour M; Jefferson Institute of Molecular Medicine and Scleroderma Center, Thomas Jefferson University, Philadelphia, PA, USA.
  • Pauling J; University of Melbourne, Melbourne at St. Vincent's Hospital Melbourne, Victoria, Australia.
  • Riemekasten G; Royal National Hospital for Rheumatic Diseases, Bath, UK; University of Lübeck, University Clinic of Schleswig-Holstein, Dept Rheumatology and Clinical Immunology, Lübeck, Germany.
  • Russell AM; University of Exeter, College of Medicine and Health, Exeter, UK.
  • Scholand MB; University of Utah, Division of Pulmonary Medicine, Pulmonary Fibrosis Center, Salt Lake City, UT, USA.
  • Seigart E; Department of Rheumatology and Clinical Immunology Charité - Universitätsmedizin Berlin and Berlin Institute of Health, Berlin, Germany.
  • Rodriguez-Reyna TS; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Best Pract Res Clin Rheumatol ; 35(3): 101707, 2021 09.
Article en En | MEDLINE | ID: mdl-34538573
ABSTRACT
Systemic sclerosis (SSc), the most lethal of rheumatologic conditions, is the cause of death in >50% of SSc cases, led by pulmonary fibrosis followed by pulmonary hypertension and then scleroderma renal crisis (SRC). Multiple other preventable and treatable SSc-related vascular, cardiac, gastrointestinal, nutritional and musculoskeletal complications can lead to disability and death. Vascular injury with subsequent inflammation transforming to irreversible fibrosis and permanent damage characterizes SSc. Organ involvement is often present early in the disease course of SSc, but requires careful history-taking and vigilance in screening to detect. Inflammation is potentially reversible provided that treatment intensity quells inflammation and other immune mechanisms. In any SSc phenotype, opportunities for early treatment are prone to be under-utilized, especially in slowly progressive phenotypes that, in contrast to severe progressive ILD, indolently accrue irreversible organ damage resulting in later-stage life-limiting complications such as pulmonary hypertension, cardiac involvement, and malnutrition. A single SSc patient visit often requires much more physician and staff time, organization, vigilance, and direct management for multiple organ systems compared to other rheumatic or pulmonary diseases. Efficiency and efficacy of comprehensive SSc care enlists trending of symptoms and bio-data. Financial sustainability of SSc care benefits from understanding insurance reimbursement and health system allocation policies for complex patients. Sharing care between recognised SSc centers and local cardiology/pulmonary/rheumatology/gastroenterology colleagues may prevent complications and poor outcomes, while providing support to local specialists. As scleroderma specialists, we offer a practical framework with tools to facilitate an optimal, comprehensive and sustainable approach to SSc care. Improved health outcomes in SSc relies upon recogntion, management and, to the extent possible, prevention of SSc and treatment-related complications.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Pulmonares Intersticiales / Hipertensión Pulmonar Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Humans Idioma: En Revista: Best Pract Res Clin Rheumatol Asunto de la revista: REUMATOLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Pulmonares Intersticiales / Hipertensión Pulmonar Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Humans Idioma: En Revista: Best Pract Res Clin Rheumatol Asunto de la revista: REUMATOLOGIA Año: 2021 Tipo del documento: Article